Table 6.
Adverse prenatal composite outcome (APCO)* and individual adverse perinatal outcomes in 106 pregnant women who were positive for SARS‐CoV‐2 infection, according to COVID‐19 symptoms
| Outcome | Asymptomatic (n = 57) | Symptomatic (n = 49) | P | Mild symptoms (n = 30) | Severe symptoms (n = 19) |
|---|---|---|---|---|---|
| APCO | 10 (17.5) | 9 (18.4) | 1.0 | 3 | 6 |
| Abnormal Doppler findings | 5 (8.7) | 3 (6.1) | 0.72 | 1 | 2 |
| SGA fetus with or without abnormal Doppler findings | 7 (12.3) | 5 (10.2) | 0.8 | 2 | 3 |
| Fetal death | 2 (3.5) | 0 | 0.5 | 0 | 0 |
| Oligohydramnios | 1 (1.8) | 2 (4.1) | 0.6 | 1 | 1 |
| Abnormal BPP | 2 (3.5) | 2 (4.1) | 1.0 | 1 | 1 |
| Preterm delivery ≤ 35 weeks | 9 (15.8) | 13 (26.5) | 0.23 | 9 | 4 |
| Low birth weight (< 10th centile) | 7 (12.3) | 5 (10.2) | 0.77 | 2 | 3 |
| 1‐min Apgar score ≤ 6 | 7 (12.3) | 5 (10.2) | 0.8 | 4 | 1 |
| 5‐min Apgar score ≤ 6 | 3 (5.3) | 2 (4.1) | 1.0 | 1 | 1 |
Data are given as n (%) or n.
*
APCO included any one or more of: small‐for‐gestational age (SGA), oligohydramnios (defined as amniotic fluid index < 5 and/or maximum vertical pocket < 2 cm), abnormal fetal biophysical profile (BPP), abnormal Doppler velocimetry and fetal death.